Last reviewed · How we verify
Atomoxetine 80 MG
Atomoxetine 80 MG is a Small molecule drug developed by Brigham and Women's Hospital. It is currently FDA-approved. Also known as: Atomoxetine, Strattera.
Atomoxetine 80 MG, marketed by Brigham and Women's Hospital, is an established treatment in its class with a key composition patent expiring in 2028. The drug's primary strength lies in its well-established market presence and protected intellectual property. The primary risk is the potential increase in competition following the patent expiry in 2028.
At a glance
| Generic name | Atomoxetine 80 MG |
|---|---|
| Also known as | Atomoxetine, Strattera |
| Sponsor | Brigham and Women's Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Atomoxetine and DAW2022 on OSA Severity (PHASE1, PHASE2)
- A Novel Pharmacological Therapy for Obstructive Sleep Apnea (PHASE2)
- Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea (PHASE1, PHASE2)
- A Study to Test Different Ways to Measure the Effect of Atomoxetine on Impulsive Behavior in Young Adults With Attention Deficit Hyperactivity Disorder (ADHD) (NA)
- Treatment of Orthostatic Intolerance (PHASE1, PHASE2)
- A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD) (PHASE4)
- Medications for Obstructive Sleep Apnea In Children With Down Syndrome (PHASE2)
- Enhancing the Effects of Adolescent Alcohol Treatment With Atomoxetine (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Atomoxetine 80 MG CI brief — competitive landscape report
- Atomoxetine 80 MG updates RSS · CI watch RSS
- Brigham and Women's Hospital portfolio CI
Frequently asked questions about Atomoxetine 80 MG
What is Atomoxetine 80 MG?
Who makes Atomoxetine 80 MG?
Is Atomoxetine 80 MG also known as anything else?
What development phase is Atomoxetine 80 MG in?
Related
- Manufacturer: Brigham and Women's Hospital — full pipeline
- Also known as: Atomoxetine, Strattera
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing